GLP-1 & Weight Loss ETF (OZEM)
NASDAQ: OZEM
· Real-Time Price · USD
25.69
0.46 (1.84%)
At close: Aug 18, 2025, 3:59 PM
26.20
1.99%
After-hours: Aug 18, 2025, 07:51 PM EDT
1.84% (1D)
| Bid | 26.18 |
| Market Cap | 32.6M |
| AUM | 31.3M |
| NAV | 23.71 |
| EPS (ttm) | 1.12 |
| PE Ratio (ttm) | 22.84 |
| Shares Out | 1.27M |
| Inception Date | May 20, 2024 |
| Ask | 27 |
| Volume | 29.13K |
| Open | 25.54 |
| Previous Close | 25.23 |
| Day's Range | 25.54 - 25.77 |
| 52-Week Range | 20.01 - 29.21 |
| Holdings | 29 |
| Expense Ratio | 0.59% |
About OZEM
Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Asset Class Equity
Ticker Symbol OZEM
Inception Date May 20, 2024
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 66.11% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 14.12% |
| Novo Nordisk A/s | NVO | 14.04% |
| Viking Therapeutics,... | VKTX | 6.54% |
| Roche Holding Ag | ROG.SW | 5.07% |
| Innovent Biologics I... | 1801.HK | 4.90% |
| Zealand Pharma A/s | ZEAL.CO | 4.63% |
| Terns Pharmaceutical... | TERN | 4.59% |
| Pfizer Inc. | PFE | 4.43% |
| Metsera, Inc. | MTSR | 3.91% |
| Chugai Pharmaceutica... | 4519.T | 3.88% |
Dividends Dividend Yield 0.22%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
